The Gatifloxacin Ophthalmic Solution, cataloged under National Stock Number 6505-01-713-4881, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-713-4881 |
| Primary Part Number | NDC61314-0672-25 |
| Item Name | Gatifloxacin Ophthalmic Solution |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Inc. |
| Status | ACTIVE |
| Administration | OPHTHALMIC |
| Primary Container Content Quantity | 2.5 MILLILITERS |
| Features Provided | STERILE |
| Primary Container Type | BOTTLE |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 5.0 PERCENTAGE, V/V GATIFLOXACIN BY VOLUME |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC61314-0672-25 PRIMARY | Sandoz Inc. (USA) |
| NDC00378-5431-35 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM239168 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1654572 | 5/1 Secondary reference U.S. Government activity |
| ZYMAXID | 5/1 Secondary reference Allergan Usa Inc |
NSN 6505-01-713-4881 is a Gatifloxacin Ophthalmic Solution, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-713-4881 has 2 manufacturer part numbers on file: NDC61314-0672-25 (Sandoz Inc.), NDC00378-5431-35 (Mylan Pharmaceuticals Inc).
Key specifications for NDC61314-0672-25: Administration: OPHTHALMIC; Primary Container Content Quantity: 2.5 MILLILITERS; Features Provided: STERILE; Primary Container Type: BOTTLE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.